Senior Site Reliability Engineer, Docplanner

Salary not provided

+ Share options plan after 6 months

AWS
Kubernetes
Python
.NET
Go
Prometheus
Datadog
Senior and Expert level
Barcelona
Remote from Spain
Docplanner

Operating system for healthcare

Job no longer available

Docplanner

Operating system for healthcare

1001+ employees

HealthcareB2CB2BPersonal healthMarketplaceInternal toolsSaaS

Job no longer available

Salary not provided

+ Share options plan after 6 months

AWS
Kubernetes
Python
.NET
Go
Prometheus
Datadog
Senior and Expert level
Barcelona
Remote from Spain

1001+ employees

HealthcareB2CB2BPersonal healthMarketplaceInternal toolsSaaS

Company mission

To help people live longer, healthier lives.

Company mission

To help people live longer, healthier lives.

Top investors

11% employee growth in 12 months

Our take

Healthcare platform Docplanner has become a major player in the European healthtech market. The company offers a suite of administrative tools for over 22M patients and more than 2.8M doctors worldwide, including workflow digitisation and appointment booking services. The company currently operate in 13 countries, hit Unicorn status in 2021, and has been riding a wave of digital transformation and workforce overburdening in the healthcare sector which has spurred on demand for precisely the kind of services they provide. So it’s safe to say business is going well.

What makes Docplanner particularly compelling is its consistent expansion strategy and focus on building an integrated healthcare ecosystem. Through acquisitions such as Germany's Jameda and Polish tech solutions provider MyDr, the company has strengthened both its geographical reach and technological capabilities. These moves reflect the wider maturation of the healthtech sector, with Docplanner positioning itself as one of the leading platforms shaping the future of digital healthcare in Europe and beyond.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Funding (last 2 of 6 rounds)

May 2019

$89.6m

SERIES E

May 2017

$16.6m

SERIES D

Total funding: $140.6m

This company has top investors